Allovir, Inc. Quarterly Debt-to-equity in % from Q1 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Allovir, Inc. quarterly Debt-to-equity history and growth rate from Q1 2021 to Q2 2024.
  • Allovir, Inc. Debt-to-equity for the quarter ending June 30, 2024 was 22.8 %, a 3.93% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 22.8 +0.86 +3.93% Jun 30, 2024
Q1 2024 25.4 +3.02 +13.5% Mar 31, 2024
Q4 2023 26.5 +5.4 +25.6% Dec 31, 2023
Q3 2023 24.9 +2.78 +12.6% Sep 30, 2023
Q2 2023 21.9 -0.88 -3.86% Jun 30, 2023
Q1 2023 22.4 +4.62 +26% Mar 31, 2023
Q4 2022 21.1 +7.16 +51.5% Dec 31, 2022
Q3 2022 22.1 +13.1 +145% Sep 30, 2022
Q2 2022 22.8 +16.6 +271% Jun 30, 2022
Q1 2022 17.7 +10.2 +135% Mar 31, 2022
Q4 2021 13.9 Dec 31, 2021
Q3 2021 9.01 Sep 30, 2021
Q2 2021 6.14 Jun 30, 2021
Q1 2021 7.55 Mar 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.